title: Recent developments in second and third line therapy of metastatic renal cell carcinoma.
authors.affiliation: a UOSC Oncologia , Azienda Ospedaliera di Rilievo Nazionale 'Antonio Cardarelli' , Naples , Italy.
authors.forename: Maria Giuseppa
authors.initials: MG
authors.lastname: Vitale
authors.affiliation: a UOSC Oncologia , Azienda Ospedaliera di Rilievo Nazionale 'Antonio Cardarelli' , Naples , Italy.
authors.forename: Giacomo
authors.initials: G
authors.lastname: Cartenì
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009362:Neoplasm Metastasis
chemical_list: D000970:Antineoplastic Agents
keywords: Cabozantinib; government funding; metastatic; nivolumab; renal cell cancer; second line; therapy; third line